Reduced Intensive Idarubicin and Cytarabine Plus Venetoclax as First-line Treatment for Adults AML and MDS
Clinical trial NCT06050941 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06050941
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-02
- Primary completion
- 2026-04-02
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.